FURIEX PHARMACEUTICALS, INC. Research and Development Expense
FURIEX PHARMACEUTICALS, INC. reported Research and Development Expense of $14.28 million for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2014-05-09
- FURIEX PHARMACEUTICALS, INC. research and development expense for the quarter ending 2014-03-31 was $14.28M, a 43.70% decline year-over-year.
- FURIEX PHARMACEUTICALS, INC. research and development expense for the quarter ending 2013-12-31 was $15.39M, a 5.55% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. research and development expense for the quarter ending 2013-09-30 was $19.89M, a 34.44% increase year-over-year.
- FURIEX PHARMACEUTICALS, INC. research and development expense for the quarter ending 2013-06-30 was $22.05M, a 28.30% decline year-over-year.
- FURIEX PHARMACEUTICALS, INC. research and development expense for fiscal 2013 was $82.70M, a 18.99% increase from fiscal 2012.
- FURIEX PHARMACEUTICALS, INC. research and development expense for fiscal 2012 was $69.50M, a 57.24% increase from fiscal 2011.
- FURIEX PHARMACEUTICALS, INC. research and development expense for fiscal 2011 was $44.20M, a 11.79% decline from fiscal 2010.
- FURIEX PHARMACEUTICALS, INC. research and development expense for fiscal 2010 was $50.11M, a 324.86% increase from fiscal 2009.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2014-03-31 | $14.28M 10-Q · filed 2014-05-09 | $29.67M derived: sum of 2 quarters · filed 2014-05-09 | $49.57M derived: sum of 3 quarters · filed 2014-05-09 | $71.62M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | $15.39M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $35.29M derived: sum of 2 quarters · filed 2014-03-17 | $57.34M derived: sum of 3 quarters · filed 2014-03-17 | $82.70M 10-K · filed 2014-03-17 |
| 2013-09-30 | $19.89M 10-Q · filed 2013-11-12 | $41.95M derived: sum of 2 quarters · filed 2013-11-12 | $67.31M 10-Q · filed 2013-11-12 | $81.89M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-06-30 | $22.05M 10-Q · filed 2013-08-08 | $47.41M 10-Q · filed 2013-08-08 | $62.00M derived: sum of 3 quarters · filed 2014-05-09 | $76.80M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-03-31 | $25.36M 10-Q · filed 2014-05-09 | $39.95M derived: sum of 2 quarters · filed 2014-05-09 | $54.75M derived: sum of 3 quarters · filed 2014-05-09 | $85.50M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | $14.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $29.38M derived: sum of 2 quarters · filed 2014-03-17 | $60.14M derived: sum of 3 quarters · filed 2014-03-17 | $69.50M 10-K · filed 2014-03-17 |
| 2012-09-30 | $14.80M 10-Q · filed 2013-11-12 | $45.55M derived: sum of 2 quarters · filed 2013-11-12 | $54.92M 10-Q · filed 2013-11-12 | $61.00M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-06-30 | $30.75M 10-Q · filed 2013-08-08 | $40.12M 10-Q · filed 2013-08-08 | $46.20M derived: sum of 3 quarters · filed 2014-03-17 | $58.22M derived: sum of 4 quarters · filed 2014-03-17 |
| 2012-03-31 | $9.37M 10-Q · filed 2013-05-09 | $15.45M derived: sum of 2 quarters · filed 2014-03-17 | $27.47M derived: sum of 3 quarters · filed 2014-03-17 | $40.69M derived: sum of 4 quarters · filed 2014-03-17 |
| 2011-12-31 | $6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $18.10M derived: sum of 2 quarters · filed 2014-03-17 | $31.32M derived: sum of 3 quarters · filed 2014-03-17 | $44.20M 10-K · filed 2014-03-17 |
| 2011-09-30 | $12.02M 10-Q · filed 2012-11-06 | $25.25M derived: sum of 2 quarters · filed 2012-11-06 | $38.12M 10-Q · filed 2012-11-06 | $48.01M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $13.22M 10-Q · filed 2012-08-07 | $26.10M 10-Q · filed 2012-08-07 | $35.98M derived: sum of 3 quarters · filed 2013-03-18 | $55.98M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $12.88M 10-Q · filed 2012-05-07 | $22.76M derived: sum of 2 quarters · filed 2013-03-18 | $42.76M derived: sum of 3 quarters · filed 2013-03-18 | $56.12M derived: sum of 4 quarters · filed 2013-03-18 |
| 2010-12-31 | $9.88M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $29.88M derived: sum of 2 quarters · filed 2013-03-18 | $43.24M derived: sum of 3 quarters · filed 2013-03-18 | $50.11M 10-K · filed 2013-03-18 |
| 2010-09-30 | $19.99M 10-Q · filed 2011-11-10 | $33.35M derived: sum of 2 quarters · filed 2011-11-10 | $40.23M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | $13.36M 10-Q · filed 2011-08-10 | $20.23M 10-Q · filed 2011-08-10 | ||
| 2009-12-31 | $11.79M 10-K · filed 2012-03-07 |